ReviewCell host & microbe2026
Pleiotropic roles of microbial bile acid metabolism in intestinal health and diseases.
Review in Cell host & microbe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Perturbation of microbial-derived bile acid (BA) metabolism is strongly linked to the pathogenesis of intestinal diseases, including inflammatory bowel disease, enteric infections, and colorectal cancer. Recent advances in artificial intelligence-assisted pipelines have enabled the identification of BA modification reactions, which have uncovered novel targets and the mechanisms contributing to intestinal diseases. In this review, we summarize recent studies on microbial enzymatic pathways and modifications of BAs, and their roles in promoting or preventing intestinal diseases. The mechanisms altering gut microbiota populations and microbial BA metabolic landscapes that influence intestinal diseases are further examined along with how microbial-derived BAs modulate intestinal immune responses. Based on these advances, we suggest different dietary patterns that reshape the gut microbiota community and BAs to prevent intestinal diseases. We further discuss current challenges in basic and translational research on microbial BA modifications in intestinal homeostasis and propose future directions to drive progress in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.